PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation
Activation of cultured hepatic stellate cells correlated with an enhanced expression of proteins involved in uptake and storage of fatty acids (FA translocase CD36, Acyl-CoA synthetase 2) and retinol (cellular retinol binding protein type I, CRBP-I; lecithin:retinol acyltransferases, LRAT). The incr...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2003-02-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520312153 |
id |
doaj-4199ff612a9a4144983a88fe13821af9 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Karine Hellemans Krista Rombouts Erik Quartier Andrea S. Dittié Andreas Knorr Liliane Michalik Vera Rogiers Frans Schuit Walter Wahli Andrea Geerts |
spellingShingle |
Karine Hellemans Krista Rombouts Erik Quartier Andrea S. Dittié Andreas Knorr Liliane Michalik Vera Rogiers Frans Schuit Walter Wahli Andrea Geerts PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation Journal of Lipid Research liver fibrosis peroxisome proliferator-activated receptor β fatty acid binding protein CD36 ACS2 cellular retinol binding protein |
author_facet |
Karine Hellemans Krista Rombouts Erik Quartier Andrea S. Dittié Andreas Knorr Liliane Michalik Vera Rogiers Frans Schuit Walter Wahli Andrea Geerts |
author_sort |
Karine Hellemans |
title |
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation |
title_short |
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation |
title_full |
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation |
title_fullStr |
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation |
title_full_unstemmed |
PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation |
title_sort |
pparβ regulates vitamin a metabolism-related gene expression in hepatic stellate cells undergoing activation |
publisher |
Elsevier |
series |
Journal of Lipid Research |
issn |
0022-2275 |
publishDate |
2003-02-01 |
description |
Activation of cultured hepatic stellate cells correlated with an enhanced expression of proteins involved in uptake and storage of fatty acids (FA translocase CD36, Acyl-CoA synthetase 2) and retinol (cellular retinol binding protein type I, CRBP-I; lecithin:retinol acyltransferases, LRAT). The increased expression of CRBP-I and LRAT during hepatic stellate cells activation, both involved in retinol esterification, was in contrast with the simultaneous depletion of their typical lipid-vitamin A (vitA) reserves. Since hepatic stellate cells express high levels of peroxisome proliferator activated receptor β (PPARβ), which become further induced during transition into the activated phenotype, we investigated the potential role of PPARβ in the regulation of these changes. Administration of L165041, a PPARβ-specific agonist, further induced the expression of CD36, B-FABP, CRBP-I, and LRAT, whereas their expression was inhibited by antisense PPARβ mRNA. PPARβ-RXR dimers bound to CRBP-I promoter sequences.Our observations suggest that PPARβ regulates the expression of these genes, and thus could play an important role in vitA storage. In vivo, we observed a striking association between the enhanced expression of PPARβ and CRBP-I in activated myofibroblast-like hepatic stellate cells and the manifestation of vitA autofluorescent droplets in the fibrotic septa after injury with CCl4 or CCl4 in combination with retinol. |
topic |
liver fibrosis peroxisome proliferator-activated receptor β fatty acid binding protein CD36 ACS2 cellular retinol binding protein |
url |
http://www.sciencedirect.com/science/article/pii/S0022227520312153 |
work_keys_str_mv |
AT karinehellemans pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT kristarombouts pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT erikquartier pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT andreasdittie pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT andreasknorr pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT lilianemichalik pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT verarogiers pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT fransschuit pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT walterwahli pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation AT andreageerts pparbregulatesvitaminametabolismrelatedgeneexpressioninhepaticstellatecellsundergoingactivation |
_version_ |
1721507006632689664 |
spelling |
doaj-4199ff612a9a4144983a88fe13821af92021-04-27T04:39:21ZengElsevierJournal of Lipid Research0022-22752003-02-01442280295PPARβ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activationKarine Hellemans0Krista Rombouts1Erik Quartier2Andrea S. Dittié3Andreas Knorr4Liliane Michalik5Vera Rogiers6Frans Schuit7Walter Wahli8Andrea Geerts9Laboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandLaboratory of Molecular Liver Cell Biology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Molecular Pharmacology Unit, Vrije Universiteit Brussel, 1090 Brussels Belgium; Diabetes Research Center, Department of Toxicology, Vrije Universiteit Brussel, 1090 Brussels Belgium; Bayer AG, Institute for Cardiovascular Research, Wuppertal, Germany; Institute for Animal Biology, University of Lausanne, SwitzerlandActivation of cultured hepatic stellate cells correlated with an enhanced expression of proteins involved in uptake and storage of fatty acids (FA translocase CD36, Acyl-CoA synthetase 2) and retinol (cellular retinol binding protein type I, CRBP-I; lecithin:retinol acyltransferases, LRAT). The increased expression of CRBP-I and LRAT during hepatic stellate cells activation, both involved in retinol esterification, was in contrast with the simultaneous depletion of their typical lipid-vitamin A (vitA) reserves. Since hepatic stellate cells express high levels of peroxisome proliferator activated receptor β (PPARβ), which become further induced during transition into the activated phenotype, we investigated the potential role of PPARβ in the regulation of these changes. Administration of L165041, a PPARβ-specific agonist, further induced the expression of CD36, B-FABP, CRBP-I, and LRAT, whereas their expression was inhibited by antisense PPARβ mRNA. PPARβ-RXR dimers bound to CRBP-I promoter sequences.Our observations suggest that PPARβ regulates the expression of these genes, and thus could play an important role in vitA storage. In vivo, we observed a striking association between the enhanced expression of PPARβ and CRBP-I in activated myofibroblast-like hepatic stellate cells and the manifestation of vitA autofluorescent droplets in the fibrotic septa after injury with CCl4 or CCl4 in combination with retinol.http://www.sciencedirect.com/science/article/pii/S0022227520312153liver fibrosisperoxisome proliferator-activated receptor βfatty acid binding proteinCD36ACS2cellular retinol binding protein |